Peaks Curative Review

What Peaks Curative charges

• Sermorelin: $169.99 — the category listing names no billing period, and the product page carries no figure at all
• NAD+: $169.99 — the category listing names no billing period, and the product page carries no figure at all
• NAD+: $129.99 — the category listing names no billing period
• PT-141: $139.99 — a one-time price; a subscription is offered at $125.99 every four weeks

The letter is on this entity, not a name that resembles it

A warning letter issued in February 2026 names Peaks Curative, LLC trading as Peaks. It is attached here on the strength of the document itself.

The letter's opening cites peakscurative.com as the content the agency reviewed, and its recipient contact is an address at that same domain.

The pharmacy the seller names was screened separately against the federal table and carries no letter of its own.

It answers the FDA question both ways

Its about page says "Our treatments are FDA-approved or cleared, where applicable".

Its FAQ says "The compounded products offered on peaknow.com use FDA approved active pharmaceutical ingredients (API). Compounded products are not FDA approved."

Those two sentences cannot both describe the same products. Both are recorded and neither is corrected here, because the seller has not corrected either.

Nine states are stated; fifty are offered at checkout

It names them: "Our doctors and pharmacy are licensed in Florida, New York, Rhode Island, Colorado, New Jersey, Delaware, Pennsylvania, Nevada and Arizona."

Every product page nonetheless carries a buy control headed "Confirm your State before purchasing" listing all fifty, and the site's own FAQ asks "Why is Peak Now unable to ship to my state?".

The nine are a statement; the fifty are a form control. Only the nine are credited here.

It names a pharmacy, and hides three prices on a category page

It identifies its dispenser as a legal entity: "you may select RxCompoundStore.com, LLC or, if applicable, any one of our partner pharmacies (collectively, the 'Peaks Pharmacy Network')".

Its sermorelin, NAD+ injection and NAD+ nasal products print no figure at all on their own product pages; the price exists only on the category listing above them.

The domain shopped is not the one the brand is named after — peakscurative.com redirects to peaknow.com, a pairing its terms confirm by naming both.

FDA disclosure

Peaks Curative received an FDA warning letter issued February 2026. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.

How we verified this

• Followed peakscurative.com through its redirect to peaknow.com and confirmed the pairing against the seller's own terms before reading any figure.
• Read the about page and the FAQ in the same session and recorded both FDA statements verbatim rather than choosing between them.
• Read the nine-state sentence and the fifty-state buy control separately, and credited only the sentence.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Confirmed the February 2026 warning letter belongs to this seller from the letter's own opening line, which names the seller's website, and from the recipient contact at that domain; the named pharmacy was screened separately and carries none.